Document is current
Any future updates will be listed below
-
Authors
Owji, Aaron P.
Dong, Jingyun
Kittredge, Alec https://orcid.org/0000-0002-8140-9267
Wang, Jiali https://orcid.org/0000-0002-9520-8140
Zhang, Yu https://orcid.org/0000-0002-6525-2458
Yang, Tingting https://orcid.org/0000-0002-5220-588X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM149252, R01GM127652)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R24EY028758)
Irma T. Hirschl Trust (CU20-4313)
Research to Prevent Blindness (CU22-1892)
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 15 November 2024
First Online: 30 December 2024
Competing interests
: Provisional Patents on glutamate (no. 63/693,687) and GABA/PABA (no. 63/693,686) analogs as bestrophin activators have been filed, listing A.P.O., Y.Z., and T.Y. as inventors. The remaining authors declare no competing interests.
